The treatment outcome of any cancer usually depends on the stage at which the cancer has been detected and its extent that is whether it has spread to the neighbouring tissues. In case of esophageal cancer, the prognosis is usually poor and approximately 10% of the diagnosed patients survive for 5 years after the diagnosis. Total surgical resection of the tumor is possible only for around 50% of the patients that too with eventual complications like anastomotic fistulas, subphrenic abscesses and cardiopulmonary complications. When employing chemotherapy, significant reductions in the measurable size of tumors in 15-20% of patients on single agent and around 30-60% of patients given drug combinations where one of the drugs is platinum based (cisplatin, carboplatin, etc.)